Đang chuẩn bị liên kết để tải về tài liệu:
Immunotherapy and associated immunerelated adverse events at a large UK centre: A mixed methods study

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The development and rapid uptake of immune checkpoint inhibitors (CPI) has changed the outlook for patients with cancer. However, CPIs have different adverse event (AE) profiles to other systemic therapies, and prompt AE management is essential to assure optimal outcomes. |

TÀI LIỆU LIÊN QUAN

ADVANCEMENTS IN TUMOR IMMUNOTHERAPY AND CANCER VACCINES

Innate Immune Regulation and Cancer Immunotherapy

Cancer immunotherapy: A review

Safety and short-term outcomes of gastrectomy after preoperative chemotherapy plus immunotherapy versus preoperative chemotherapy: A retrospective cohort study

Implications of Population Aging for Economic Growth

Communicable Disease Flip-Chart

CDC’s Vision for Public Health Surveillance in the 21st Century

Interactive Food & Beverage Marketing: Targeting Children and Youth in the Digital Age

IAS VERSUS U.S. GAAP: INFORMATION ASYMMETRY-BASED EVIDENCE FROM GERMANY'S NEW MARKET

Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment - Subgroup Report on the Lowermoor Water Pollution Incident